Agentix Corp Sustainability Reports
Agentix Corp. is a clinical-stage biotechnology company that develops synthetic and natural cannabinoid therapeutics targeting the endocannabinoid system. The company focuses on the development of novel biopharmaceuticals to treat metabolic diseases, peripheral neuropathy, and progressive lung disease.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG0068Q8V85
No reports are currently available in our catalogue.